Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. News
  7. Summary
    AMGN   US0311621009

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Amgen : Discover What Fosters Innovation and Drives Change Through Amgen's Innovation2 Series

10/08/2021 | 03:12pm EST

Where does innovation start and how can creativity grow within an organization? What motivates people to think differently and ultimately change the status quo?

Amgen and The Nation of Artists set out to answer some of these burning questions through a series of virtual conversations called Innovation2.

Throughout the series, pioneers in science, technology and business engage in inspiring conversations about innovation and highlight their personal contributions to today's cutting-edge science and innovation.

New episodes uncover how innovators inspire others and drive change, as well as what motivates them:

  • Ep 1: Changing a Mindset : Phuong Khanh (PK) Morrow, vice president of Global Development at Amgen, meets with Mike Pell, director of The Microsoft Garage, a program that delivers experiences to employees, customers, and partners that drive collaboration, creativity and experimentation.
  • Ep 2: Nurturing Innovation: Ray Deshaies, senior vice president of Global Research at Amgen meets with Iranian-born American businesswomen and first Muslim woman to travel into space, Anousheh Ansari, CEO of XPRIZE Foundation, a non-profit organization that designs and hosts public competitions intended to encourage technological development to benefit humanity.
  • Ep 3: Making an Impact: Cathy Critchlow, vice president of Research and Development Data Strategy at Amgen, meets with Lauryn Nwankpa, Head of Social Impact at Dave, a fintech company helping people to improve their financial health.
  • Ep 4: It Takes Tenacity< /a>: Peter Kufer, vice president and Innovator of BiTE® Technology at Amgen, meets with David Putrino, Head of Rehabilitation Innovation at Mount Sinai Hospital, a health care system in New York City providing medical care to local and global communities.
  • Ep 5: A Lesson in Perseverance : Rusty Lipford, director of Inflammation and Oncology Research at Amgen meets with Aaron Horowitz, co-founder & CEO of Sproutel, a patient-centered research and design studio that develops products focused on improving health outcomes.

The first three episodes are also live on The Verge, a multimedia source covering accelerating technological change in ways that are impactful to a broad audience, interested in technology, science, art and culture.

Future episodes coming in 2021 dive into how innovators push against the status quo to make a difference in the world and utilize synchronicity to drive change.

Be on the lookout for episodes featuring Amgen leaders such as:

  • Synchronicity, a Catalyst: with David Reese, executive vice president of Research and Development at Amgen and James Reese, Former Chief Operations Engineer and "Head Neurosurgeon" at Google
  • Changing the Status Quo: with Rob Lenz, senior vice president of Global Development at Amgen and Aprille Ericsson, Aerospace Engineer at NASA

The series has already gained award-winning recognition, taking home four Platinum Hermes Creative Awards in the following categories: Documentary, Motion Graphic, YouTube Video and Original Music.

To stay up to date on the latest episodes of Innovation2 and to see more from our participants, follow Amgen Oncology's Twitter and LinkedIn channels and Amgen's YouTube, Twitter, Facebook, Instagram and LinkedIn channels.

Disclaimer

Amgen Inc. published this content on 08 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 October 2021 19:11:04 UTC.


ę Publicnow 2021
All news about AMGEN INC.
11/29AMGEN : Every Patient Counts, Every Story Matters
PU
11/29Amgen Named To Dow Jones Sustainability World Index For Eighth Consecutive Year
PR
11/29BRISTOL-MYERS SQUIBB : Deucravacitinib Applications Advance in U.S., Europe
DJ
11/24Amgen To Present At The 2021 Evercore ISI Healthcare Conference
PR
11/24Amgen To Present At The 2021 Piper Sandler Healthcare Conference
PR
11/23AMGEN : In a First for Industry, Murielle Veniant-Ellison Honored With 2022 Havel Lectures..
PU
11/22AMGEN : Supporting Access to Nutritious Foods in Amgen's Community
PU
11/22WALL STREET STOCK EXCHANGE : Covid spike has many consequences on stock markets
11/22ANALYST RECOMMENDATIONS : Activision Blizzard, Amgen, Ebay, Vmware, Xcel Energy...
11/22Mizuho Securities Cuts Amgen's Price Target to $194 From $222, Citing 'Potential 2022 H..
MT
More news
Analyst Recommendations on AMGEN INC.
More recommendations
Financials (USD)
Sales 2021 26 018 M - -
Net income 2021 5 551 M - -
Net Debt 2021 22 411 M - -
P/E ratio 2021 20,6x
Yield 2021 3,42%
Capitalization 115 B 115 B -
EV / Sales 2021 5,27x
EV / Sales 2022 4,94x
Nbr of Employees 24 300
Free-Float 99,8%
Chart AMGEN INC.
Duration : Period :
Amgen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 203,47 $
Average target price 238,86 $
Spread / Average Target 17,4%
EPS Revisions
Managers and Directors
Robert A. Bradway Chairman, President & Chief Executive Officer
Peter H. Griffith Chief Financial Officer & Executive Vice President
David M. Reese Executive Vice President-Research & Development
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Mike Zahigian Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
AMGEN INC.-11.50%114 608
JOHNSON & JOHNSON1.16%420 557
ROCHE HOLDING AG15.70%334 662
PFIZER, INC.42.35%294 114
NOVO NORDISK A/S67.75%247 392
ELI LILLY AND COMPANY50.93%231 027